Title:
【発明の名称】腫瘍治療の複合療法としてインテグリン拮抗物質と一つ以上の抗腫瘍剤を使用する方法
Document Type and Number:
Japanese Patent JP2002533387
Kind Code:
A
Abstract:
The present invention provides methods to treat neoplasia disorders in a mammal using a combination of radiation and an integrin antagonist.
Inventors:
McKern, John, Pea.
Gordon, Gerry
Cunningham, James, Jay.
Gatley, Stephen, Tee.
Footjob, Alain, Tee.
Mas Ferrar, James, Elle.
Gordon, Gerry
Cunningham, James, Jay.
Gatley, Stephen, Tee.
Footjob, Alain, Tee.
Mas Ferrar, James, Elle.
Application Number:
JP2000590619A
Publication Date:
October 08, 2002
Filing Date:
December 22, 1999
Export Citation:
Assignee:
G.D.Searle & Company
International Classes:
A61K31/00; A61K31/07; A61K31/122; A61K31/135; A61K31/136; A61K31/138; A61K31/16; A61K31/165; A61K31/166; A61K31/18; A61K31/191; A61K31/192; A61K31/197; A61K31/198; A61K31/203; A61K31/255; A61K31/28; A61K31/282; A61K31/337; A61K31/341; A61K31/351; A61K31/353; A61K31/36; A61K31/381; A61K31/402; A61K31/415; A61K31/4162; A61K31/4164; A61K31/4168; A61K31/4178; A61K31/4184; A61K31/4188; A61K31/4196; A61K31/42; A61K31/421; A61K31/422; A61K31/425; A61K31/427; A61K33/243; A61K31/429; A61K45/00; A61K31/435; A61K31/4353; A61K31/437; A61K31/4375; A61K31/44; A61K31/4402; A61K31/4418; A61K31/4427; A61K31/4433; A61K31/4439; A61K31/444; A61K31/445; A61K31/4453; A61K31/45; A61K31/451; A61K31/4535; A61K31/4545; A61K31/4709; A61K31/4741; A61K31/4745; A61K31/475; A61K31/496; A61K31/501; A61K31/505; A61K31/506; A61K31/51; A61K31/519; A61K31/525; A61K31/541; A61K31/55; A61K31/5513; A61K31/566; A61K31/567; A61K31/569; A61K31/57; A61K31/575; A61K31/66; A61K31/664; A61K31/675; A61K31/704; A61K31/7048; A61K31/7068; A61K33/04; A61K33/10; A61K38/00; A61K39/395; A61K41/00; A61K45/06; A61P1/00; A61P11/00; A61P13/10; A61P15/00; A61P15/14; A61P17/00; A61P35/00; A61P41/00; A61P43/00; C07D211/54; C07D211/66; C07D211/96; C07D213/74; C07D261/18; C07D309/08; C07D401/06; C07D401/12; C07D403/12; C07D405/12; C07D413/12; C07D417/12; C07D471/04; C07K5/023; C07K5/062; C07K16/18; (IPC1-7): A61K45/00; A61K31/122; A61K31/138; A61K31/192; A61K31/197; A61K31/198; A61K31/203; A61K31/282; A61K31/337; A61K31/36; A61K31/4168; A61K31/4178; A61K31/4196; A61K31/42; A61K31/429; A61K31/4375; A61K31/4402; A61K31/4535; A61K31/4545; A61K31/4709; A61K31/4741; A61K31/475; A61K31/505; A61K31/506; A61K31/525; A61K31/5513; A61K31/567; A61K31/57; A61K31/575; A61K31/664; A61K31/675; A61K31/704; A61K31/7068; A61K33/24; A61K38/00; A61P35/00; A61P43/00
Attorney, Agent or Firm:
Yasuo Ishikawa
Previous Patent: 年齢関連器官機能不全および年齢関連疾患予防および寿命延長のための薬...
Next Patent: 睡眠発作治療のための、ガンマ−ヒドロキシ酪酸塩の微生物的に安全で安...
Next Patent: 睡眠発作治療のための、ガンマ−ヒドロキシ酪酸塩の微生物的に安全で安...